Mass General Brigham, MIT Launch Joint Seed Program to Drive Innovation

The MIT-MGB Seed Program has been established to accelerate healthcare innovations through a collaboration between MIT and Mass General Brigham, funded by Analog Devices Inc. This initiative aims to support the development of next-generation therapies, diagnostics, and digital tools by combining MIT's technological expertise with MGB's clinical knowledge. By fostering interdisciplinary research, the program will highlight advancements in artificial intelligence and machine learning, ultimately driving innovation in medical care. The initiative will fund approximately six projects annually over three years, along with entrepreneurial workshops to facilitate the transition from lab research to practical applications in healthcare.

Opens on MIT News